5-HT1A receptor blockade potentiates the subjective effects of DMT.
Zarmeen Zahid, Rick J Strassman, Clifford R Qualls, Sandeep M Nayak
Journal of psychopharmacology (Oxford, England) May 2, 2026 Peer reviewed DOI: 10.1177/02698811261443696 via PubMed
Summary
Pindolol pre-treatment enhances the subjective effects of DMT, a serotonergic psychedelic, in individuals with hallucinogen experience. In a study involving 12 participants, those who received a sub-hallucinogenic dose of DMT after taking pindolol reported increased subjective effects, with a moderate effect size of 0.514. Additionally, blood pressure and mean arterial pressure rose shortly after DMT administration, while heart rate remained unchanged. This suggests that blocking the 5-HT1A receptor intensifies the subjective experience induced by psychedelics.
Study at a glance
| Design | double-blind, randomized, placebo-controlled within-subjects |
|---|---|
| Sample size | 12 |
| Population | experienced hallucinogen-using participants |
| Key finding | Pindolol pre-treatment increased DMT-induced subjective effects, indicating a role for 5-HT1A receptor blockade in enhancing these effects. |
Abstract
Serotonergic psychedelics are being investigated in the treatment of various disorders and in the improvement of well-being. Evidence suggests that their subjective effects may play a role in long-term behavioral outcomes. The subjective effects are mediated by 5-HT2A receptor agonism, but the 5-HT1A receptor may also play a role in the subjective effects. This study elucidates the effects of 5-HT1A receptor blockade using pindolol pre-treatment on the subjective effects induced by N,N-dimethyltryptamine (DMT). In a double-blind, randomized, placebo-controlled within-subjects design, 12 (10 males, 2 females) experienced hallucinogen-using participants received a sub-hallucinogenic dose of intravenous DMT fumarate, 0.1 mg/kg, after pre-treatment with 30 mg oral racemic pindolol. Subjective effects were measured using the Hallucinogen Rating Scale. Pindolol pre-treatment increased DMT-induced subjective effects with a moderate effect size (M = 0.514). Blood pressure and mean arterial pressure also increased with pindolol pre-treatment at 2 minutes following DMT administration, but heart rate was not affected. 5-HT1A receptor blockade results in a global intensification of DMT-induced subjective effects, suggesting a functional role of 5-HT1A receptor action in the mechanism of psychedelic-induced subjective effects.